S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 07:25 PM ET

EDXC

Endexx Corporation

Price Chart
Latest Quote

$0.00

+0.00 (+0.00%)
Current Price
Previous Close $0.00
Open $0.00
Day High $0.00
Day Low $0.00
Volume 1,000,011
Fetched: 2026-06-19T23:25:51
Stock Information
Shares Outstanding 571.85M
Total Debt $12.46M
Cash Equivalents $24K
Revenue $4.64M
Net Income $6.89M
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Market Cap $57K
Exchange PNK
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$13.49M
Sales$4.64M
Income$6.89M
Book/sh$-0.03
Cash/sh$0.00
Financial Ratios
Quick Ratio0.02
Current Ratio0.09
Returns & Margins
ROA-31.03%
Gross Margin28.62%
Operating Margin-632.56%
Profit Margin148.63%
Ownership
Insider Ownership5.61%
Insider & Institutional transactions data not available
Valuation Ratios
P/S0.01
P/B-0.00
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.00
SMA50$0.00
SMA200$0.00
RSInan
ATR0.0000
Shares Float478.99M
Volatility-0.49
Performance History
Week+0.00%
Month+0.00%
Quarter+0.00%
6 Months-93.75%
YTD-87.50%
Year-98.31%
3 Years-99.76%
5 Years-99.93%
10 Years-99.66%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $0.00 0
2026-06-17 $0.00 0
2026-06-16 $0.00 104,550
2026-06-15 $0.00 4,870
2026-06-12 $0.00 0
2026-06-11 $0.00 0
2026-06-10 $0.00 41,397
2026-06-09 $0.00 1,115
2026-06-08 $0.00 0
2026-06-05 $0.00 3,756
2026-06-04 $0.00 0
2026-06-03 $0.00 0
2026-06-02 $0.00 0
2026-06-01 $0.00 409,000
2026-05-29 $0.00 0
2026-05-28 $0.00 0
2026-05-27 $0.00 0
2026-05-26 $0.00 6,000
2026-05-22 $0.00 52,179
2026-05-21 $0.00 45,575
2026-05-20 $0.00 0
2026-05-19 $0.00 100,000
About Endexx Corporation

Endexx Corporation develops and sells hemp-derived products for the health and wellness market under the CBD Unlimited brand in the United States and internationally. The company offers cannabidiol oils, topicals, capsules, snacks, and beverages, as well as equine products for dogs and cats under the PhytoBites brand. It serves medical, biotech, and life science industries. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. The company is based in Cave Creek, Arizona.

📰 Latest News
No news articles available at the moment. Check back later for updates on EDXC.
Period:
Loading...
Income Statement (Annual)
Metric 2022-09-30 2021-09-30
Revenue
Reconciled Cost Of Revenue $944,900 $994,593
Cost Of Revenue $944,900 $994,593
Total Revenue $2,138,010 $650,515
Operating Revenue $2,138,010 $650,515
Expenses
Interest Expense $1,241,853 $950,549
Total Expenses $5,805,264 $6,021,844
Other Income Expense $2,721,845 $802,251
Other Non Operating Income Expenses $289,100 -
Net Non Operating Interest Income Expense $-4,199,151 $-2,239,076
Total Other Finance Cost $2,957,298 $1,288,527
Interest Expense Non Operating $1,241,853 $950,549
Operating Expense $4,860,364 $5,027,251
Selling And Marketing Expense $594,874 $1,778,073
General And Administrative Expense $4,217,818 $3,218,633
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-4,884,468 $-6,808,154
Net Interest Income $-4,199,151 $-2,239,076
Normalized Income $-7,317,213 $-7,610,405
Net Income From Continuing And Discontinued Operation $-4,884,468 $-6,808,154
Total Operating Income As Reported $-3,916,814 $-5,371,329
Net Income Common Stockholders $-4,884,468 $-6,808,154
Net Income $-4,884,468 $-6,808,154
Net Income Including Noncontrolling Interests $-5,144,560 $-6,808,154
Net Income Continuous Operations $-5,144,560 $-6,808,154
Pretax Income $-5,144,560 $-6,808,154
Special Income Charges $-410,348 $-91,576
Operating Income $-3,667,254 $-5,371,329
Depreciation Amortization Depletion Income Statement $20,606 $20,400
Depreciation And Amortization In Income Statement $20,606 $20,400
Depreciation Income Statement $20,606 $20,400
Gross Profit $1,193,110 $-344,078
Per Share
Diluted EPS $-0.01 $-0.01
Basic EPS $-0.01 $-0.01
Other
Tax Effect Of Unusual Items $0 $0
Tax Rate For Calcs $0 $0
Normalized EBITDA (Bullshit earnings) $-6,314,846 $-6,639,456
Total Unusual Items $2,432,745 $802,251
Total Unusual Items Excluding Goodwill $2,432,745 $802,251
Reconciled Depreciation $20,606 $20,400
EBITDA (Bullshit earnings) $-3,882,101 $-5,837,205
EBIT $-3,902,707 $-5,857,605
Diluted Average Shares $503,983,723 $455,049,510
Basic Average Shares $503,983,723 $455,049,510
Diluted NI Availto Com Stockholders $-4,884,468 $-6,808,154
Minority Interests $260,092 $0
Gain On Sale Of Ppe $423,950 $0
Other Special Charges $584,738 $91,576
Write Off $249,560 $0
Gain On Sale Of Security $2,843,093 $893,827
Research And Development $27,066 $10,145
Selling General And Administration $4,812,692 $4,996,706
Other Gand A $3,608,530 $2,581,140
Salaries And Wages $609,288 $637,493
Restructuring And Mergern Acquisition - $0
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2022-09-30 2021-09-30
Assets
Net Tangible Assets $-19,257,179 $-10,003,391
Total Assets $13,278,390 $1,759,913
Total Non Current Assets $9,906,196 $725,831
Non Current Prepaid Assets $0 $250,000
Non Current Note Receivables $1,500,000 $0
Investmentin Financial Assets $420 $9,920
Goodwill And Other Intangible Assets $9,823,611 $16,250
Other Intangible Assets $16,250 $16,250
Current Assets $3,372,194 $1,034,082
Prepaid Assets $1,367,100 $41,648
Inventory $777,912 $920,812
Receivables $570,406 $50,755
Accounts Receivable $570,406 $50,755
Allowance For Doubtful Accounts Receivable $-621,042 $-58,257
Gross Accounts Receivable $1,191,448 $109,012
Cash Cash Equivalents And Short Term Investments $656,776 $20,867
Cash And Cash Equivalents $656,776 $20,867
Cash Financial $656,776 $20,867
Debt
Net Debt $9,354,389 $6,881,028
Total Debt $10,046,821 $6,901,895
Long Term Debt And Capital Lease Obligation $4,587,718 $248,200
Long Term Debt $4,587,718 $248,200
Current Debt And Capital Lease Obligation $5,459,103 $6,653,695
Current Debt $5,423,447 $6,653,695
Other Current Borrowings $5,423,447 $6,653,695
Liabilities
Total Liabilities Net Minority Interest $22,972,050 $11,747,054
Total Non Current Liabilities Net Minority Interest $4,587,718 $248,200
Current Liabilities $18,384,332 $11,498,854
Other Current Liabilities $8,908,686 $1,799,354
Current Deferred Liabilities $43,366 $36,705
Payables And Accrued Expenses $3,973,177 $3,009,100
Interest Payable $237,703 $1,095,248
Payables $3,434,658 $1,646,517
Total Tax Payable $787,125 $626,053
Accounts Payable $2,647,533 $1,020,464
Equity
Common Stock Equity $-11,433,750 $-9,987,395
Preferred Stock Equity $2,000,182 $254
Total Equity Gross Minority Interest $-9,693,660 $-9,987,141
Stockholders Equity $-9,433,568 $-9,987,141
Retained Earnings $-44,398,312 $-39,513,844
Long Term Equity Investment $2,000,000 $0
Other
Ordinary Shares Number $501,376,264 $486,313,058
Share Issued $501,376,264 $486,313,058
Tangible Book Value $-21,257,361 $-10,003,645
Invested Capital $-1,422,585 $-3,085,500
Working Capital $-15,012,138 $-10,464,772
Capital Lease Obligations $35,656 $0
Total Capitalization $-4,845,850 $-9,738,941
Minority Interest $-260,092 $0
Additional Paid In Capital $32,914,424 $29,477,818
Capital Stock $2,050,320 $48,885
Common Stock $50,138 $48,631
Preferred Stock $2,000,182 $254
Current Deferred Revenue $43,366 $36,705
Current Capital Lease Obligation $35,656 $0
Current Accrued Expenses $538,519 $1,362,583
Investments And Advances $420 $9,920
Available For Sale Securities $420 $9,920
Goodwill $9,807,361 $0
Net PPE $82,165 $449,661
Accumulated Depreciation $-77,044 $-75,388
Gross PPE $159,209 $525,049
Other Properties $34,160 -
Machinery Furniture Equipment $125,049 $105,049
Buildings And Improvements $0 $305,800
Land And Improvements $0 $114,200
Properties $0 $0
Inventories Adjustments Allowances $-1,071,469 $-1,001,542
Other Inventories $173,321 $324,689
Finished Goods $1,427,017 $1,187,096
Raw Materials $249,043 $410,569
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2022-09-30 2021-09-30
Free Cash Flow
Free Cash Flow $-2,088,304 $-3,720,267
Operating Activities
Operating Cash Flow $-2,088,304 $-3,720,267
Cash Flow From Continuing Operating Activities $-2,088,304 $-3,720,267
Operating Gains Losses $-3,267,043 $-893,827
Investing Activities
Investing Cash Flow $-573,763 $0
Cash Flow From Continuing Investing Activities $-573,763 $0
Net Other Investing Changes $-1,500,000 -
Financing Activities
Issuance Of Capital Stock $0 $328,000
Financing Cash Flow $3,297,976 $3,736,484
Cash Flow From Continuing Financing Activities $3,297,976 $3,736,484
Net Common Stock Issuance $0 $328,000
Common Stock Issuance $0 $328,000
Other
Repayment Of Debt $0 $-20,750
Issuance Of Debt $3,297,976 $3,429,234
Interest Paid Supplemental Data $75,061 $58,780
Income Tax Paid Supplemental Data $0 $0
End Cash Position $656,776 $20,867
Beginning Cash Position $20,867 $4,650
Changes In Cash $635,909 $16,217
Net Issuance Payments Of Debt $3,297,976 $3,408,484
Net Short Term Debt Issuance $2,964,853 $1,614,234
Short Term Debt Issuance $2,964,853 $1,614,234
Net Long Term Debt Issuance $333,123 $1,794,250
Long Term Debt Payments $0 $-20,750
Long Term Debt Issuance $333,123 $1,815,000
Net Investment Purchase And Sale $9,500 $0
Sale Of Investment $9,500 $0
Net Business Purchase And Sale $916,737 $0
Sale Of Business $916,737 $0
Change In Working Capital $1,586,595 $1,454,653
Change In Other Working Capital $1,496 -
Change In Payables And Accrued Expense $2,692,411 $1,734,759
Change In Accrued Expense $1,567,172 $1,134,777
Change In Interest Payable $1,166,432 $891,769
Change In Payable $1,125,239 $599,982
Change In Account Payable $1,125,239 $599,982
Change In Prepaid Assets $-195,590 $-42,088
Change In Inventory $-35,442 $-216,704
Change In Receivables $-876,280 $-21,314
Changes In Account Receivables $-876,280 $-21,314
Other Non Cash Items $3,252,836 $1,380,103
Stock Based Compensation $455,800 $721,021
Asset Impairment Charge $1,007,462 $405,537
Depreciation Amortization Depletion $20,606 $20,400
Depreciation And Amortization $20,606 $20,400
Gain Loss On Investment Securities $-2,843,093 $-893,827
Net Income From Continuing Operations $-5,144,560 $-6,808,154
Net Intangibles Purchase And Sale - $0
Purchase Of Intangibles - $0
Net PPE Purchase And Sale - $0
Purchase Of PPE - $0
Fetched: 2026-02-02